ADVANCED ENZYME TECHNOLOGIES LTD.
Market Cap.(`)
|
4416.49 Cr.
|
P/BV
|
4.06
|
Book Value (`)
|
97.35
|
52 Week High/Low ( ` )
|
425/266
|
FV/ML
|
2/1
|
P/E(X)
|
41.81
|
Book Closure
|
05/08/2023
|
EPS (`)
|
9.45
|
Div Yield (%)
|
1.27
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 140.39 | 171.06 | 210.37 | 179.16 | 161.96 |
| | | | | |
Net CashFlow From Operating Activities | 140.36 | 122.29 | 162.89 | 140.90 | 128.57 |
Net Cash Used In Investing Activities | -298.18 | -24.91 | -26.03 | -44.50 | -124.65 |
Net Cash Used From Financing Activities | -25.80 | -27.38 | -26.31 | -38.55 | -43.09 |
Foreign Exchange Gains / Losses | 12.66 | 5.43 | -1.90 | 1.75 | 1.11 |
Adjustments On Amalgamation / Merger / Demerger And Others | 0.02 | 0.00 | 0.60 | 0.00 | 0.00 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -170.94 | 75.44 | 109.26 | 59.60 | -38.07 |
Cash And Cash Equivalents Begin of Year | 267.36 | 191.92 | 82.66 | 23.06 | 61.13 |
Cash And Cash Equivalents End Of Year | 96.42 | 267.36 | 191.92 | 82.66 | 23.06 |